Literature DB >> 12468828

Long-term follow-up of 246 adults with juvenile idiopathic arthritis: predictive factors for mood and pain.

J C Packham1, M A Hall, T J Pimm.   

Abstract

OBJECTIVE: To examine the predictive factors for anxiety, depression and pain in adults with juvenile idiopathic arthritis (JIA). PATIENTS AND METHODS: Two hundred and forty-six adults identified with long-standing JIA had an average disease duration of 28.3 yr. Candidate factors potentially predictive for pain, anxiety and depression were assessed by multiple regression analysis.
RESULTS: Of the patients, 31.6% were anxious, 5.2% were depressed, and 21.1% had previously suffered from depression. The percentage of the variance accounted for by other variables was 78.8 for anxiety variance and 54.5 for depression, but there was little influence from physical disease-related factors. Severe pain, measured on a visual analogue scale, occurred in 32.9% of patients, and 22.8% had poor perceived control over their pain. Function, coping strategies, pain self-efficacy, inflammation and previous depression could predict 39.6% of the variance in pain.
CONCLUSIONS: Comparing adults with children, disease activity and control over pain remain predictors of pain but become less important than disability and coping strategies.

Entities:  

Mesh:

Year:  2002        PMID: 12468828     DOI: 10.1093/rheumatology/41.12.1444

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  39 in total

Review 1.  Transition of care from paediatric to adult rheumatology.

Authors:  Janet E McDonagh
Journal:  Arch Dis Child       Date:  2007-09       Impact factor: 3.791

2.  Anti-CCP antibodies in Brazilian children and adults with juvenile idiopathic arthritis.

Authors:  S Bacos; S G Bortolozzi; T S Skare; P F Spelling; S R R Utiyama; R Nisihara
Journal:  Clin Rheumatol       Date:  2014-03-21       Impact factor: 2.980

3.  Decreased use of non-steroidal anti-inflammatory drugs for the treatment of juvenile idiopathic arthritis in the era of modern aggressive treatment.

Authors:  Rabina Kochar; Kyle M Walsh; Anil Jain; Steven J Spalding; Philip J Hashkes
Journal:  Rheumatol Int       Date:  2011-09-11       Impact factor: 2.631

Review 4.  Juvenile idiopathic arthritis: the paediatric perspective.

Authors:  Alison Jordan; Janet E McDonagh
Journal:  Pediatr Radiol       Date:  2006-05-11

5.  Population-based study of outcomes of patients with juvenile idiopathic arthritis (JIA) compared to non-JIA subjects.

Authors:  Megan L Krause; Jorge A Zamora-Legoff; Cynthia S Crowson; Theresa Wampler Muskardin; Thomas Mason; Eric L Matteson
Journal:  Semin Arthritis Rheum       Date:  2016-07-18       Impact factor: 5.532

6.  Articular damage in adults with juvenile idiopathic arthritis.

Authors:  Eda Gurcay; Emel Eksioglu; Serdil Yuzer; Ajda Bal; Aytul Cakci
Journal:  Rheumatol Int       Date:  2008-10-14       Impact factor: 2.631

7.  High rates of unsuccessful transfer to adult care among young adults with juvenile idiopathic arthritis.

Authors:  Elizabeth Hazel; Xun Zhang; Ciarán M Duffy; Sarah Campillo
Journal:  Pediatr Rheumatol Online J       Date:  2010-01-11       Impact factor: 3.054

8.  Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry.

Authors:  Pamela F Weiss; Timothy Beukelman; Laura E Schanberg; Yukiko Kimura; Robert A Colbert
Journal:  J Rheumatol       Date:  2012-10-15       Impact factor: 4.666

Review 9.  Using Patient-Reported Outcome Measures to Capture the Patient's Voice in Research and Care of Juvenile Idiopathic Arthritis.

Authors:  Aimee O Hersh; Parissa K Salimian; Elissa R Weitzman
Journal:  Rheum Dis Clin North Am       Date:  2016-03-18       Impact factor: 2.670

10.  Challenges in the management of juvenile idiopathic arthritis with etanercept.

Authors:  Clare E Pain; Liza J McCann
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.